A cost-utility analysis comparing intensive chemotherapy alone to intensive chemotherapy followed by myeloablative chemotherapy with autologous stem-cell rescue in newly diagnosed patients with stage II/III multiple myeloma: a prospective randomised phase III study

✍ Scribed by M. van Agthoven; C.M. Segeren; I. Buijt; C.A. Uyl-de Groot; B. van der Holt; H.M. Lokhorst; P. Sonneveld

• Book ID: 116428124
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 334 KB
• Volume: 40
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/j.ejca.2004.01.019